ENO2 and neoplasm: The AUC calculation elucidated the power of cfDNA levels to discriminate the tumor burden of newly diagnosed NB from stable disease NB, and the AUC for cfDNA levels was better able to discriminate the tumor burden than the AUC of NSE or LDH levels (Figure 2).